Product Pathways - Apoptosis
Bax Antibody (Human Specific) #2774
|2774S||100 µl (10 western blots)||---||In Stock||---|
|2774||carrier free and custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation, IHC-P=Immunohistochemistry (Paraffin)
Specificity / Sensitivity
Bax Antibody (Human-Specific) detects endogenous levels of total Bax protein. Cross-reativity was not detected with other family members at physiological conditions.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding lysine 58 of human Bax. Antibodies were purified by protein A and peptide affinity chromatography.
Western blot analysis of extracts from 293, HT-1080 and Raji cell lines using Bax Antibody #2772 (left) and Bax Antibody (Human Specific) #2774 (right).
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using Bax Antibody (Human Specific).
Immunohistochemical analysis of paraffin-embedded human Non-Hodgkin's lymphoma using Bax Antibody (Human Specific).
Bax is a key component for cellular induced apoptosis through mitochondrial stress (1). Upon apoptotic stimulation, Bax forms oligomers and translocates from the cytosol to the mitochondrial membrane (2). Through interactions with pore proteins on the mitochondrial membrane, Bax increases the membrane's permeability, which leads to the release of cytochrome c from mitochondria, activation of caspase-9 and initiation of the caspase activation pathway for apoptosis (3,4).
- Chacko, A.D. et al. (2010) BMC Cancer 10, 380. Applications: Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.